VERA - Vera Therapeutics GAAP EPS of -$0.45 beats by $0.08
2023-11-09 13:15:35 ET
More on Vera Therapeutics
- Vera Therapeutics' Promising Atacicept Drug Targets IgAN
- Guggenheim starts Vera at buy, sees IgAN drug as "well positioned"
- Seeking Alpha’s Quant Rating on Vera Therapeutics
- Historical earnings data for Vera Therapeutics
- Financial information for Vera Therapeutics
For further details see:
Vera Therapeutics GAAP EPS of -$0.45 beats by $0.08